Cargando…
Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses
The COVID-19 pandemic began at the end of 2019 in Wuhan, China, and has spread throughout the world. Vaccination is still the most effective method of prevention of pathogenic infections, including viral infections. However, there is little evidence that vaccination can protect against SARS-CoV-2 vi...
Autores principales: | Yurina, Valentina, Rahayu Adianingsih, Oktavia, Widodo, Nashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869617/ https://www.ncbi.nlm.nih.gov/pubmed/36712897 http://dx.doi.org/10.1016/j.jvacx.2023.100265 |
Ejemplares similares
-
Predicting epitopes for vaccine development using bioinformatics
tools
por: Yurina, Valentina, et al.
Publicado: (2022) -
Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein
por: Tang, Lijie, et al.
Publicado: (2009) -
Oral Immunization of Mice with Cell Extracts from Recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein
por: Xuan, Biao, et al.
Publicado: (2022) -
Safety Evaluation of an Intranasally Applied Cocktail of Lactococcus lactis Strains in Pigs
por: Rattigan, Ruth, et al.
Publicado: (2023) -
Expanding the recombinant protein quality in Lactococcus lactis
por: Cano-Garrido, Olivia, et al.
Publicado: (2014)